Cowen Reiterates Outperform Rating and $150 PT on Lam Research (LRCX) Following 1Q EPS / Revenue Beat
Cowen reiterates Outperform rating and $150 price target on Lam Research (NASDAQ: LRCX), as the company reported ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
